July 2012

  • Elizabeth Futrell

    JHU∙CCP | Technical Writer
    PRB 2012 Datasheet

    The Population Reference Bureau's 2012 World Population Data Sheet

    With the recent publication of its 2012 World Population Data Sheet, the Population Reference Bureau (PRB) marked the 50th anniversary of this valuable source of information. This year’s data sheet, which includes 19 population, health, and environment indicators for more than 200 countries, devotes much attention to noncommunicable diseases (NCDs), now the leading cause of death in all regions of the world except sub-Saharan Africa. Even in sub-Saharan Africa, NCDs will account for nearly half of all deaths by 2030.
     
    Last week, Wendy Baldwin, PRB president and CEO, and Carl Haub, senior demographer, hosted a webinar to unveil the new fact sheet. The talk highlighted the four NCDs that are currently driving global mortality: cardiovascular disease, diabetes, chronic respiratory diseases, and cancer. Baldwin and Haub pointed out that tobacco use, diet, obesity, sedentary lifestyle, and excessive alcohol consumption are responsible for half of the risk from NCDs. Watch the video below to hear Wendy Baldwin talk about what youth can do to prevent NCDs.
     
     

     

  • Jarret Cassaniti

    JHU∙CCP | Communications Specialist

    Much of the information conveyed at the International AIDS Conference (AIDS 2012) was fresh and exciting to me and built on news that comes to me via my social networks.  As a relative newcomer to the field of mHealth, I gained a lot of insight into the buzz surrounding the field at the conference.  A topic I have been meditating about this week was discussed in a workshop on Showcasing the Potential and Role of Mobile Technology in Turning the Tide on HIV and Other Diseases.  An audience member encouraged us to look at the parallels between mHealth and mBanking since they both aim to make sensitive information accessible to the end user but added the caveat that healthcare is more complex and involves more data points.

    In Amplifying the Impact: Examining the Intersection of Mobile Health and Mobile Finance, a discussion guide for collaborative insight presented by the World Economic Forum, in partnership with the mHealth Alliance, the potential synergistic relationship is framed beside the staggering numbers people who lack banking and health services:

  • Stephen Goldstein

    JHU∙CCP | Senior Consultant

    September 2014 will mark the 20th anniversary of the International Conference on Population and Development in Cairo, Egypt.

    Shortly before the 1994 Cairo meeting, I remember riding down in a New York elevator following a pre-conference meeting with a bunch of family planning NGO communicators. We had just agreed on a mutual message that women should have the right to choose when and how many children to have. This might seem “ho hum” now, but at the time it was a sea change from the traditional global “over population” argument that appeared in most of our  press releases showing the global rise in population over the next 10, 20, 30 years.

    At Population Reports, we had just published a report on  The Environment and Population Growth: Decade for Action, and in preparation were reports on Winning the Food Race and Solutions for a Water-Short World.  Fortunately for me, we had also recently published in 1992 The Reproductive Revolution: New Survey Findings, in which we stated: “A reproductive revolution is spreading across much of the developing world. Use of effective contraception has risen rapidly, and fertility has been falling. But there is still a long way to go. More than one woman in every five wants to avoid pregnancy but is not using contraception.” This reference to “unmet need” gave me a good reason to be in that elevator discussing our mutual message for women’s rights, even though I had one foot in the demographic/environment camp.

  • Elizabeth Futrell

    JHU∙CCP | Technical Writer

    On the eve of the London Summit for Family Planning, The Lancet published a series of articles and commentaries that explores the links between contraception, population growth, and the health and wellbeing of the planet and its current and future inhabitants. The series reviews an array of evidence on the toll that lack of access to family planning takes not only on maternal and child health but also on the social, economic, and environmental health of communities, nations, and the world.

    Abuja Nigeria Woman and Child Learn About Contraceptive Options

    A mother in Abuja, Nigeria reads a family planning and child spacing brochure to learn about contraceptive options available in the area.

    © 2012 Kim Blessing/JHU∙CCP, Courtesy of Photoshare

    Those who work in family planning are well aware that national political will and international support for contraceptive programs has waned in recent decades. This neglect has perpetuated a continued lack of access, particularly in low-resource settings where the consequences are most dire. The Lancet’s series examines the potential of family planning to advance global health from so many angles that even readers whose careers are devoted to the cause will gain fresh perspective and new insights.

    The rebirth of family planning: Herbert Peterson of the UNC Gillings School of Global Public Health, who led the planning, commissioning, and preparation of the series, and Richard Horton of The Lancet identify two central challenges to addressing unmet need: stronger advocacy to policymakers to devote more attention to family planning and translating the scientific evidence presented in this series into innovative programs that are implemented well to achieve universal access to reproductive health.

    Making family planning a national development priority: Pierre Damien Habumuremyi, Prime Minster of Rwanda, and Meles Zenawi, Prime Minister of Ethiopia, credit five factors with increased contraceptive use in the successful case studies of Rwanda and Ethiopia over the past decade:

  • Jim Shelton

    USAID | Science Advisor for the Bureau of Global Health

    Dr. Jim Shelton's Pearls is an occasional series by USAID’s Global Health Science Advisor that answers commonly asked questions about family planning. 

    Originally posted on September 1, 2010.

    Question: I understand the FDA has approved a new emergency contraceptive (EC). Can you please tell me about it?

    Answer: Yes, on August 13, 2010 the FDA approved ella (ulipristal acetate) as a new oral emergency contraceptive. Some of its attributes:

Pages